임상 한눈에 보기

• 4건의 ClinicalTrials.gov 임상 기록
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• Phase: Phase 1 · Phase 2
• Status: Completed · Terminated
• 주요 endpoint: Incidence of adverse events · Incidence of laboratory abnormalities · Objective response according to modified response criteria for acute myeloid leukemia (Cheson 2003) or revised response criteria for malignant lymphoma (Cheson 2007) · Duration of response · Overall survival
• 등록 대상자(표본 합산): 약 261명
• 핵심: The purpose of this randomized, open-label study is to evaluate the safety and efficacy of denintuzumab mafodotin plus R…

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다. 효능 수치는 선택한 등록 결과이며 전적응증 값이 아닙니다.